Assetmark, Inc Voyager Therapeutics, Inc. Transaction History

Assetmark, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $173 - $239	-44 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$7.15 - $12.28 $78 - $135	11 Added 33.33%	44 $0
Q2 2020 Aug 11, 2020	SELL	$8.05 - $14.21 $56 - $99	-7 Reduced 17.5%	33 $0
Q1 2020 May 12, 2020	SELL	$6.8 - $14.66 $122 - $263	-18 Reduced 31.03%	40 $0
Q3 2019 Nov 13, 2019	BUY	$16.31 - $28.29 $945 - $1,640	58 New	58 $1,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $208M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.